[ICNMDigital23:ISS-5]

Industry-Supported Symposium

Aging and Infectious Diseases in Myasthenia Gravis

Supported by

This program aims to review the current understanding and unmet needs of limb-girdle muscular dystrophies (LGMDs) as well as explore the rationale and clinical data for an investigational gene therapy for a particular LGMD subtype, LGMD2E/R4.

Chair and speakers

• Prof. Vera Bril, University of Toronto, Toronto, Ontario, Canada
• Prof. Nils Erik Gilhus, University of Bergen, Bergen, Norway

Introduction

• Prof. Vera Bril, University of Toronto, Toronto, Ontario, Canada

Aging in Myasthenia Gravis

• Prof. Vera Bril, University of Toronto, Toronto, Ontario, Canada

Myasthenia Gravis and Infectious Diseases

• Prof. Nils Erik Gilhus, University of Bergen, Bergen, Norway

Q&A and wrap up

• Prof. Nils Erik Gilhus
• Prof. Vera Bril